Health Professionals Urge Patients Not To Abandon Avandia Pills

Although experts with the Food and Drug Administration have voiced substantial concerns over Avandia’s heart risks, three major medical groups are warning patients not to dump the diabetes drug, Reuters reports.

According to the Endocrine Society, American Diabetes Association and the American Association of Clinical Endocrinologists, patients need to continue on their prescribed medications unless otherwise advised by their health care provider.

“Stopping diabetes medications can cause significant harm and result in higher levels of blood glucose that may cause severe short term health problems and could increase the risk of diabetes-related complications in the long term,” Dr. Robert Vigersky of the Endocrine Society said in a statement.

On Wednesday, a panel of 33 experts on an FDA advisory panel recommended keeping the drug on the market, but with significant reservations: 12 voted to withdraw Avandia, 10 voted to restrict its sales and enhance its warning labels, 7 voted only to enhance the labels, 3 voted to do nothing and one member abstained.

A similar drug, Actos, has not been shown to increase the risk of heart attack or stroke. The medical associations reminded patients that dozens of drugs exist to maintain glucose levels, but said it is not entirely clear whether Avandia presents severe risks to the heart.

“While some analyses have suggested an increased cardiovascular risk with use of the diabetes drug others have not shown substantial evidence of such an association,” said a Diabetes Association statement.

Consumer groups estimate that at least 2 million Americans take Avandia each year.

Print Print  

Like what we're doing? We'd appreciate your support.

Leave a comment